Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Amgen
Company Monitoring Page for Amgen
latest headlines for company on cafepharma
Amgen Increases Sales but Misses Estimates on Earnings
Motley Fool
Sat, 01/28/12 - 11:30 am
Tags:
Amgen
Faruqi & Faruqi, LLP Announces Investigation of Micromet, Inc.
Yahoo/BusinessWire
Sat, 01/28/12 - 11:29 am
Tags:
Micromet
,
Amgen
,
M&A
,
lawsuits
2 Biotech Acquisitions in 1 Day! Let's Throw a Party
Motley Fool
Sat, 01/28/12 - 11:28 am
Tags:
Amgen
,
Micromet
,
M&A
,
Celgene
,
Avila
The Law Firm of Weiss & Lurie Investigates Micromet, Inc.
Yahoo/BusinessWire
Sat, 01/28/12 - 11:25 am
Tags:
Micromet
,
Amgen
,
M&A
,
lawsuits
10 Health Care Stocks to Watch
The Street
Sat, 01/28/12 - 11:21 am
Tags:
Alexion
,
Gilead Sciences
,
Biogen Idec
,
Amgen
,
Becton Dickinson
,
Celgene
,
Intuitive Surgical
,
Eli Lilly
,
St. Jude Medical
,
Stryker
Biotech Equities Continue To Benefit From Discoveries And Acquisitions In 2012
Seeking Alpha
Fri, 01/27/12 - 11:08 am
Tags:
Alexion
,
Amgen
,
Ariad
,
Biogen Idec
,
Bristol-Myers Squibb
,
Celgene
,
Gilead
,
Illumina
,
Inhibitex
,
Vertex Pharmaceuticals
Amgen Misses Fourth-Quarter Profit Estimates as Anemia Drug Sales Tumble
Bloomberg
Fri, 01/27/12 - 10:35 am
Tags:
Amgen
,
earnings
Amgen Agrees to Purchase Micromet for $1.16 Billion to Gain Leukemia Drug
Bloomberg
Thu, 01/26/12 - 01:09 pm
Tags:
Amgen
,
M&A
,
Micromet
,
leukemia
Why Amgen Is Overvalued At $70 A Share
Seeking Alpha
Mon, 01/23/12 - 12:46 pm
Tags:
Amgen
Forbes Earnings Preview: Amgen
Forbes
Mon, 01/23/12 - 11:01 am
Tags:
earnings
,
Amgen
10 Biotech Stocks With Strong Corporate Governance
Seeking Alpha
Wed, 01/18/12 - 10:03 am
Tags:
Amgen
,
Achillion
,
Chelsea Therapeutics
,
Charles River Laboratories
,
Indenix
,
Human Genome Sciences
,
Incyte
,
Immunogen
,
NPS Pharmaceuticals
,
PDL Biopharma
Why Big Pharma Doesn't Really Need (Or Even Want) A Pipeline
Seeking Alpha
Tue, 01/17/12 - 06:48 pm
Tags:
Adolor
,
Alexion
,
Amgen
,
Cubist Pharmaceuticals
,
AstraZeneca
,
Bristol-Myers Squibb
,
Inhibitex
,
Merck
,
Pfizer
,
Stryker
How Does Amgen Boost Its Returns?
Motley Fool
Sun, 01/15/12 - 01:37 pm
Tags:
Amgen
7 Large-Cap Biotech Equities With Strong Momentum Right Now
Seeking Alpha
Sat, 01/14/12 - 11:32 am
Tags:
Amgen
,
Ariad Pharmaceuticals
,
Biogen
,
Celgene
,
Gilead Sciences
,
Vertex Pharmaceuticals
30% Safe Upside For Merck, Amgen
Seeking Alpha
Thu, 01/12/12 - 10:54 am
Tags:
Amgen
,
Merck
Celldex Therapeutics: A Potential Triple With Data On The Way
Seeking Alpha
Wed, 01/11/12 - 10:58 am
Tags:
Celldex
,
Amgen
,
Bristol-Myers Squibb
,
Dendreon
,
Seattle Genetics
,
Exelixis
Next Amgen CEO sees expansion to new markets, higher sales from newer products, share buybacks
Yahoo/AP
Tue, 01/10/12 - 09:05 am
Tags:
Amgen
,
Pharma CEOs
,
Robert Bradway
2 ETFs To Play A Surge In Biotech/Pharma M&A
Seeking Alpha
Mon, 01/9/12 - 10:39 am
Tags:
Abbott Laboratories
,
Amgen
,
Biogen Idec
,
Gilead
,
Celgene
,
Bristol-Myers Squibb
,
JNJ
,
Eli Lilly
,
Merck
,
Pfizer
,
ETFs
Five Myths You’ll Hear This Week at the JP Morgan Healthcare Conference
Xconomy
Mon, 01/9/12 - 10:10 am
Tags:
JPMorgan
,
IPOs
,
Amgen
,
FDA
,
innovation
The Magic Formula for Biotech
Motley Fool
Sun, 01/8/12 - 12:50 pm
Tags:
Gilead
,
Amgen
Pages
« first
‹ previous
…
79
80
81
82
83
84
85
86
87
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.